SCHEMBL17714854

SCHEMBL17714854

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c5ccccc5n(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)c4c3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ ATM Q13315 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ AVPR1A P37288 1/20 0.39
▸ MAT2A P31153 1/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ IL1R1 P14778 1/20 0.38
▸ MEN1 O00255 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21669168 1.00 L3MBTL1 (0.51) L3MBTL1ATMKDM4EAVPR1AMAT2A
SCHEMBL20623602 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4EAVPR1AMAT2A
SCHEMBL27359021 0.99 L3MBTL1 (0.50) L3MBTL1ATMKDM4EAVPR1AMAT2A
SCHEMBL22025259 0.97 L3MBTL1 (0.55) L3MBTL1ATMKDM4EAVPR1AMAT2A
SCHEMBL17915714 0.96 L3MBTL1 (0.47) L3MBTL1ATMKDM4EAVPR1AMAT2A
SCHEMBL24152518 0.96 L3MBTL1 (0.53) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL21472379 0.96 L3MBTL1 (0.52) L3MBTL1ATMKDM4EMAT2AKMT2A
SCHEMBL12093160 0.96 L3MBTL1 (0.52) L3MBTL1ATMKDM4EMAT2AKMT2A
SCHEMBL12093171 0.96 L3MBTL1 (0.52) L3MBTL1ATMKDM4EMAT2AKMT2A
SCHEMBL17897472 0.96 L3MBTL1 (0.52) L3MBTL1ATMKDM4EMAT2AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-09-07 — — US disclosed
EP-3015465-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEMICAL LTD (KR) 2019-09-04 — — EP disclosed
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-02 — — US disclosed
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2019-04-09 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
EP-3015465-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2016-05-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 L3MBTL1 699/4885ATM 2327/4885KDM4E 1531/4885
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 L3MBTL1 699/4885ATM 2327/4885KDM4E 1531/4885
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 L3MBTL1 699/4885ATM 2327/4885KDM4E 1531/4885
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 L3MBTL1 699/4885ATM 2327/4885KDM4E 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback